Sterilized and individually packaged in a medical-grade pouch, the Microbrush Test Swabs are ready-for-use intended for clinical nasopharyngeal sample collection
Microbrush is a subsidiary of Young Innovations, Inc., a portfolio company of The Jordan Company. (Credit: Pete Linforth from Pixabay)
Microbrush, a leading US-based global manufacturer and supplier of flocked applicators, has launched a nasopharyngeal test swab to meet the growing demand for COVID-19 testing requirements.
Sterilized and individually packaged in a medical-grade pouch, the Microbrush Test Swabs are ready-for-use intended for clinical nasopharyngeal sample collection. Manufactured in Grafton, Wis., Microbrush Test Swabs are a natural product line extension, following a 30-year track record of US-manufactured applicators for the healthcare industry. Flocked with soft nylon fibers, the Microbrush Test Swab provides an improved patient experience over 3D-printed swabs.
“Microbrush has rich manufacturing expertise in this category with over 10 billion flocked applicators produced since 1991,” said Dave Sproat, CEO of Young Innovations, Inc. “With healthcare providers in great need of COVID-19 test supplies, we’re incredibly proud to do our part in supporting this critical need by bringing a significant increase in production capacity to the market right away.”
“We were uniquely positioned to develop and manufacture this product quickly due to our strict adherence to quality as an FDA-registered facility; our deep-rooted experience in flocked applicator technology; and very strong, supportive partners,” added John Frymark, Vice President of Product Development at Young Innovations. “Developed in collaboration with several leading institutions and corporations. This product launch was a true team effort and a great testament of leading businesses operating with a high sense of urgency around an immediate healthcare need.”
Source: Company Press Release